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A B S T R A C T
Background: Diffusion Tensor Imaging (DTI) can evaluate microstructural tissue damage in the optic radiation
(OR) of patients with clinically isolated syndrome (CIS), early relapsing-remitting multiple sclerosis and neu-
romyelitis optica spectrum disorders (NMOSD). Different post-processing techniques, e.g. tract-based spatial
statistics (TBSS) and probabilistic tractography, exist to quantify this damage.
Objective: To evaluate the capacity of TBSS-based atlas region-of-interest (ROI) combination with 1) posterior
thalamic radiation ROIs from the Johns Hopkins University atlas (JHU-TBSS), 2) Juelich Probabilistic ROIs
(JUEL-TBSS) and tractography methods using 3) ConTrack (CON-PROB) and 4) constrained spherical decon-
volution tractography (CSD-PROB) to detect OR damage in patients with a) NMOSD with prior ON (NMOSD-
ON), b) CIS and early RRMS patients with ON (CIS/RRMS-ON) and c) CIS and early RRMS patients without prior
ON (CIS/RRMS-NON) against healthy controls (HCs).
Methods: Twenty-three NMOSD-ON, 18 CIS/RRMS-ON, 21 CIS/RRMS-NON, and 26 HCs underwent 3 T MRI.
DTI data analysis was carried out using JUEL-TBSS, JHU-TBSS, CON-PROB and CSD-PROB. Optical coherence
tomography (OCT) and visual acuity testing was performed in the majority of patients and HCs.
Results: Absolute OR fractional anisotropy (FA) values differed between all methods but showed good correla-
tion and agreement in Bland-Altman analysis. OR FA values between NMOSD and HC differed throughout the
methodologies (p-values ranging from p < 0.0001 to 0.0043). ROC-analysis and effect size estimation revealed
higher AUCs and R2 for CSD-PROB (AUC=0.812; R2= 0.282) and JHU-TBSS (AUC=0.756; R2=0.262),
compared to CON-PROB (AUC=0.742; R2=0.179) and JUEL-TBSS (AUC=0.719; R2=0.161). Differences
between CIS/RRMS-NON and HC were only observable in CSD-PROB (AUC=0.796; R2= 0.094). No significant
differences between CIS/RRMS-ON and HC were detected by any of the methods.
Conclusions: All DTI post-processing techniques facilitated the detection of OR damage in patient groups with
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severe microstructural OR degradation. The comparison of distinct disease groups by use of different methods
may lead to different - either false-positive or false-negative - results. Since different DTI post-processing ap-
proaches seem to provide complementary information on OR damage, application of distinct methods may
depend on the relevant research question.
1. Introduction
The optic radiation (OR) is an integral part of the afferent visual
system and belongs to the most frequently affected white matter
pathways in autoimmune neuroinflammatory disorders of the central
nervous system, i.e. multiple sclerosis (MS) and neuromyelitis optica
spectrum disorders (NMOSD) (Backner et al., 2018; Balcer et al., 2015;
Bennett et al., 2015; Finke et al., 2018; Martínez-Lapiscina et al., 2014;
Pache et al., 2016a, 2016b; Pache et al., 2016a, 2016b; Petzold et al.,
2014; Pfueller and Paul, 2011; Scheel et al., 2014; Schmidt et al., 2017;
Sinnecker et al., 2015b; Wingerchuk et al., 2015). Diffusion-weighted
magnetic resonance imaging (DW-MRI) yields the potential to non-in-
vasively investigate microstructural OR integrity (Assaf and Pasternak,
2008; Filippi et al., 2013).
A multitude of DW-MRI post-processing techniques have been used
in recent studies to investigate OR damage in neuroinflammatory dis-
orders (Hasan et al., 2011). TBSS is a widely used fully automated
method to perform whole brain tract diffusion tensor imaging (DTI)
analyses. ConTrack (CON-PROB) (Sherbondy et al., 2008a, 2008b) and
CSD-based probabilistic tractography (CSD-PROB) (Lim et al., 2015;
Martínez-Heras et al., 2015; Tournier et al., 2007) provide high sensi-
tivity to delineate tracts through crossing fiber regions (Auriat et al.,
2015), facilitate the selection of pathways that connect two regions
(Sherbondy et al., 2008b) and allow subsequent in-depth analysis, for
example tract profiling, by calculating DTI values at different nodes
along the OR. However, implementation of probabilistic tractography
algorithms in the individual patient is frequently more time consuming
due to manual predefinition of seed and target regions as well as
manual or semi-automated cleaning of tractography results. Moreoever,
accurate OR delineation in vivo is hampered by its complex structure
with the sharp bending in the Meyer's loop (Martínez-Heras et al.,
2015), the reduced fiber densitiy in this area compared to the body of
the OR (Lim et al., 2015; Wu et al., 2012) and the presence of crossing
fibers along the pathway (Sherbondy et al., 2008b).
Previous investigations using CON-PROB found OR DTI metrics to
be altered in long-standing MS patients compared to healthy controls
with correlations between OR FA and OR T2 lesion volume (Klistorner
et al., 2014). A study investigating clinically isolated ON patients with
CON-PROB found reduced fractional anisotropy (FA) and elevated ra-
dial diffusivity (RD) to be associated with OR lesions. No correlation
between OR DTI and retinal nerve fiber layer thickness (RNFL) mea-
sured by optical coherence tomography (OCT) was found (Raz et al.,
2015). By contrast, investigations using TBSS in MS patients with and
without prior ON found strong correlations between RNFL and FA
within the OR, suggesting trans-synaptic neurodegeneration after ON to
explain the link between low RNFL thickness and low FA values in the
OR (Scheel et al., 2014). These contradictory results fall in line with
previous studies either favoring (Oertel et al., 2017; Pache et al., 2016a,
2016b; Reich et al., 2009; Rocca et al., 2013) or disfavoring
(Dasenbrock et al., 2011) evidence on trans-neuronal changes in neu-
roinflammatory disorders. The conflicting diversity of published DTI
studies might be partially owing to cohort inhomogeneities with re-
gards to time from disease onset, severity of structural damage and
clinical deficit as well as total and region-specific lesion load. Beyond
this, the heterogeneous usage of different DTI post-processing techni-
ques and their specific inherent limitations may account for incon-
sistent reports.
Validation studies of sensitivity, specificity and technical ad-
vantages and disadvantages of different DTI post-processing methods
are thus highly required. Unfortunately, there is no “gold-standard” for
non-invasive DTI-based OR tract-probing (Lim et al., 2015; Thomas
et al., 2014), making comparability between methods and validation of
techniques difficult. To overcome these limitations, different methods
need to be compared against each other under one specific research
question.
The purpose of our study was to compare distinct TBSS-based and
probabilistic tractography-based approaches in the delineation of OR
and the detection of OR damage. We therefore investigated OR damage
with different severity levels and compared a) NMOSD patients with
prior ON with suspected severe OR damage, b) clinically isolated syn-
drome (CIS) and early relapsing-remitting multiple sclerosis (RRMS)
patients with ON and suspected moderate OR damage and c) CIS and
early RRMS patients without prior ON and potential OR damage against
healthy controls (HCs). We evaluated inter-method agreement of FA
values and compared the capacity of all methods to detect OR FA dif-
ferences in all patient cohorts compared to HCs.
2. Material and methods
2.1. Subjects
Sixty-two patients were retrospectively analyzed from our research
database. This included CIS and early RRMS with ON (CIS/RRMS-ON),
CIS and early RRMS without ON (CIS/RRMS-NON), NMOSD with ON
(NMOSD-ON) as well as 26 HCs (see Table 1). All patients were ex-
amined under supervision of a board-certified neurologist at the Neu-
roCure Clinical Research Center, Charité-Universitätsmedizin Berlin
between January 2011 and July 2015.
Table 1
Study cohort description.
HC CIS/RRMS-NON CIS/RRMS-ON NMOSD-ON
Subjects [n] 26 21 18 23
Sex [f(m)] 22(4) 11(10) 11(7) 20(3)
Age [years; mean ± SD] 43.7 ± 15.7 33.4 ± 8.6 31.2 ± 7.7 46.7 ± 14.5
Disease duration [months; mean ± SD] n.a. 5.40 ± 6.67 4.63 ± 5.15 94.17 ± 95.72
EDSS [median; range] n.a. 1.5 (0–4.0) 1.5 (0–3.5) 4.0 (0–6.5)
RRMS diagnosis [n] n.a. 5 (23.8%) 3 (16.7%) n.a.
AQP4-ab-positive [n] n.a. n.a. n.a. 19
History of bilateral optic neuritis n.a. n.a. 0 4
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON= clinically isolated syndrome with prior optic
neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior optic neuritis; EDSS= expanded disability status scale; RRMS= relapsing-remitting
multiple sclerosis; AQP4-ab-positive=Aquaporin-4-antibody positive.
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We included 18 CIS/RRMS-ON patients from at the time of analysis
110 participants of the Berlin CIS Cohort study (ClinicalTrials.gov
Identifier: NCT01371071; EA1/182/10). CIS/RRMS-ON patients were
investigated following a first-time ON attack after 4.61 ± 5.51months
on average (range: 1–24months) and showed no other neurological
symptoms than ON-related visual dysfunction. All CIS/RRMS-ON pa-
tients presented with unilateral optic neuritis as their first clinical
symptom. At the time of MRI examination, 3 of these patients fulfilled
the 2010 revised McDonald criteria for MS (Polman et al., 2011) while
the other 15 patients had a CIS. Twenty-one CIS/RRMS-NON patients
from the same study were diagnosed as CIS (n= 16) or early RRMS
(n=5) according to the 2010 revised McDonald criteria and had a
history of only one neurological attack distinct from ON (e.g. myelitis).
Additionally, 23 patients meeting the international consensus diag-
nostic criteria for NMOSD (Wingerchuk et al., 2015) (19 Aquaporin-4-
antibody-positive: 82.6%) (Jarius et al., 2014; Metz et al., 2016;
Zekeridou and Lennon, 2015) with a clinically definitive episode of at
least one ON (NMOSD-ON) were included from at the time of analysis
53 patients of our neuromyelitis optica observational study (EA1/041/
14). NMOSD-ON patients had a time lapse from last ON of
73.2 ± 87.1 months (range: 5–404months). We enrolled 26 HCs from
our imaging research database. Patients were excluded if they 1) were
outside age range of 18–70, 2) suffered from ophthalmological defects
other than ON, 3) had a history of neurological diseases distinct from
MS or NMOSD, 4) had no available DTI acquisition. Further exclusion
criteria were similar to general exclusion criteria valid for MRI at 3 T.
Part of NMOSD-ON patients' and HCs' DTI data have been investigated
and published in a previous study (Oertel et al., 2017). All participants
provided written informed consent prior to their inclusion in the study.
The study was approved by the local ethics committee and was per-
formed in accordance with the 1964 Declaration of Helsinki in its
currently applicable version.
2.2. MRI acquisition and analysis
All MRI data were acquired on the same 3 T scanner (Tim Trio
Siemens, Erlangen, Germany) using a single-shot echo planar imaging DTI
sequence (TR/TE=7500/86ms; FOV=240×240mm2; matrix
96×96, 61 slices no gap, slice thickness 2.3mm, 64 non-colinear direc-
tions, b-value=1000 s/mm2), a volumetric high-resolution T1 weighted
magnetization prepared rapid acquisition gradient echo (MPRAGE) se-
quence (TR/TE/TI=1900/2.55/900ms, FOV=240×240mm2, matrix
240×240, 176 slices, slice thickness 1mm) as well as a volumetric high-
resolution fluid-attenuated inversion recovery sequence (3D FLAIR) (TR/
TE/TI=6000/388/2100ms; FOV=256×256mm2, slice thickness
1.0mm). 3D FLAIR images of all patients were checked and verified for
total lesion volume and OR-specific lesion volume by three expert raters
under the supervision of a board-certified radiologist. Whole-brain seg-
mentation and quantification of lesions of FLAIR images were performed
using ITK-SNAP (www.itksnap.org) (Yushkevich et al., 2006).
2.3. Image processing
2.3.1. Tract-based spatial statistics analysis (TBSS)
DTI data analysis was carried out using TBSS (Smith et al., 2006)
with tools from the FMRIB Software Library (FSL 5.0.9).
First, eddy-current and motion correction were run in FSL, then FA
images were created by fitting a tensor model to the raw diffusion data
using a least-squares algorithm in FDT, and then brain-extracted using
BET (Smith, 2002). FA data were then aligned into a common space
using the nonlinear registration tool FNIRT which uses a b-spline re-
presentation of the registration warp field. Next, the mean FA image
was created and thinned to produce a mean FA skeleton that represents
the centres of all tracts common to the group. Each subject's aligned FA
data was then projected onto this skeleton (Supplemental Fig. S1A and
B; see Supplemental material for further method description).
TBSS skeleton masks were overlaid with two different atlas masks:
(A) OR ROIs derived from the Juelich 1mm probabilistic atlas optic
radiation ROI thresholded to exclude the lowest 10% (JUEL-TBSS) and
(B) Johns Hopkins University 1mm white matter tractography prob-
abilistic atlas' posterior thalamic radiation ROI (JHU-TBSS) (Hua et al.,
2008; Wakana et al., 2007).
2.3.2. ConTrack probabilistic tractography and Vistalab tract profiling
DTI data analysis was performed using the open-source mrVista
package (http://vistalab.stanford.edu/software). Probabilistic fiber
tracking was performed using the Contrack algorithm (CON-PROB)
(Sherbondy et al., 2008a, 2008b), designed to identify the most likely
pathway between two ROIs. Prior to tractography, Eddy current-in-
duced distortion correction and motion correction were performed in
all subjects within the vistalab framework. The schematic diagram is
shown in Supplemental Fig. S1C (see also Supplemental material for
pipeline details). Fiber tensors were fitted using a least-squares algo-
rithm. The eigenvalue decomposition of the diffusion tensors was
computed and FA measures were derived along the OR bundles, at 50
equally-spaced positions, resulting in an FA tract profile (Raz et al.,
2015). Measurements were calculated by taking a weighted average of
the measurements of each individual fiber at the node (so called “fiber
core”) (Yeatman et al., 2012) to combine measures throughout the
length of the fibers across different subjects.
2.3.3. CSD-based probabilistic tractography and Vistalab tract profiling
We applied a combination of previously published OR tractography
based on high order fiber orientation distributions estimated with CSD
(CSD-PROB) (Lim et al., 2015; Martínez-Heras et al., 2015) and
weighted mean diffusivity calculation as well as tract profiling perfor-
mance in Vistalab (Yeatman et al., 2012). Probabilistic tractography
from seed to target masks was performed in each hemisphere using the
MRtrix3 package (http://www.mrtrix.org/) (Tournier et al., 2004,
2007, 2008). First, diffusion image preprocessing was performed, in-
cluding eddy current-induced distortion correction and inter-volume
subject motion correction by the use of MRtrix3-in-built usage of FSL's
eddy tool (Andersson and Sotiropoulos, 2016; Smith et al., 2004).
Maps of the fiber orientation distributions (FODs) were calculated
using CSD with a maximum harmonic order of 6 (CSD algorithm). OR
reconstruction pipeline was modified after Martínez-Heras et al. and
Lim et al. (Lim et al., 2015; Martínez-Heras et al., 2015) with non-linear
transformation of atlas ROIs in MNI space to individual T1 space using
FSL FNIRT (Smith et al., 2004) and subsequent registration of ROIs
from individual T1 space to individual DWI space using FSL FLIRT
(Jenkinson et al., 2002). The tensors were fitted using a linear least
squares approach. The schematic diagram of the pipeline is presented in
Supplemental Fig. S1D (see also Supplemental material for pipeline
details). We then used the resulting fibers to transfer them into the
Vistalab environment and compute tract profiling and weighted mean
FA of each tract modified after the procedure outlined in the CON-
PROB and Vistalab profiling section.
2.4. Optical coherence tomography and visual acuity assessment
Optical coherence tomography (OCT) investigations were per-
formed in all CIS/RRMS-NON patients, in 17 out of 18 CIS/RRMS-ON
patients, in 22 out of 23 NMOSD-ON patients and in 21 out of 26 HC
using a Heidelberg Engineering Spectralis spectral domain OCT
(Heidelberg Engineering, Heidelberg, Germany) with automatic real-
time (ART) function for image averaging. The peripapillary retinal
nerve fiber layer (pRNFL) was measured with activated eye tracker
using 3.4-mm ring scans around the optic nerve head (12°, 1536 A-
scans 16≤ART≤ 100). Segmentation of global RNFL was performed
semiautomatically using software provided by the OCT manufacturer
(Eye Explorer 1.9.10.0 with viewing module 6.0.9.0; Heidelberg
Engineering). Visual acuity tests were performed by either using ETDRS
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charts or the Traditional Snellen Eye Chart in all CIS/RRMS-NON, in 17
out of 18 CIS/RRMS-ON patients, in 21 out of 23 NMOSD-ON patients
and in 21 out of 26 HC. Visual testing outcomes were converted in
decimals.
2.5. Statistical analysis
For statistical analysis we used Graphpad Prism 6.0 (Graphpad
Software, San Diego, CA, USA) software and R version 3.1.2 with
packages psych, geepack, irr, ICC, lme4, ROCt and ggplot. For com-
parison and correlation of absolute FA values between methods we used
separate FA values of left and right OR and conducted a two-way re-
peated measures ANOVA to account for the effect of 1) method choice
and 2) OR side on FA values within each patient group and an intraclass
correlation coefficient (ICC) analysis. Agreement of FA values between
methods was evaluated by Pearson's correlation coefficient analysis and
Bland-Altman plots (BA-analysis within Graphpad Prism 6.0).
Exploratory comparisons of patient groups regarding T2 lesion vo-
lume, RNFL and visual acuity of worse eye were conducted using one-
way ANOVA. For group comparisons and correlation analyses with
clinical data, we combined FA measures of left and right optic radiation
and calculated the simple mean of both values in JHU-TBSS, JUEL-TBSS
and CON-PROB. Since OR volumes differed between right and left side
in CSD-PROB, we used weighted mean of both values for CSD-PROB
based group comparison and correlation analyses. Comparisons of pa-
tient groups regarding FA values were assessed using linear model
analyses to account for FA values with subsequent R2 effect size mea-
sures estimation. A receiver operating characteristic (ROC) analysis was
used to assess sensitivity and specificity of methods to discriminate each
patient group from healthy controls corrected for age. Comparison of
tract profiles was conduected using two-way ANOVA comparing FA
values of patient groups in every node against HC group. Correction for
multiple comparison was performed using Bonferroni correction.
Correlations between OR FA values and OR T2 lesion volume, RNFL and
visual acuity were performed using linear model analysis. For all sta-
tistical analyses, a p-value of< 0.05 was regarded as significant. Data
are presented as mean ± SD, except for tract profling results that are
displayed in mean ± standard error of the mean (SEM).
3. Results
3.1. Method comparison
3.1.1. Image processing quality
All four methods successfully generated visually appropriate OR
tracts, with the exception of one subject in the CIS/RRMS-ON group
using the CSD-PROB method.
Fig. 1. Absolute FA values of different DTI post-processing methods.
Optic radiation FA values are shown for A healthy controls (HC), B CIS patients without prior optic neuritis, C CIS patients with optic neuritis in their medical history
and D NMOSD-ON patients. Comparison of FA distribution yielded significant differences between all methods except for the comparison of JHU-TBSS and CSD-
PROB in CIS/RRMS-NON, CIS/RRMS-ON and NMOSD-ON patients.
JUEL-TBSS= Juelich-based atlas ROI TBSS approach; JHU-TBSS= Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-
PROB=ConTrack-based probabilistic tractography. CSD-PROB= constrained spherical deconvolution based probabilistic tractography. TBSS= tract-based spatial
statistics.
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3.1.2. Coefficient of variation in healthy controls
Coefficient of variation in HC group was lowest in JUEL-TBSS
(3.99%) and highest in CON-PROB (13.54%) with comparable coeffi-
cients of variation in JHU-TBSS (5.88%) and CSD-PROB (7.21%).
3.1.3. Comparison of FA values between methods
Absolute FA value distribution of the different methods for ORs of
both sides within each subject group are shown in Fig. 1 (separate left
and right OR FA values are shown in Fig. S2). Two-way repeated
measures ANOVA revealed a significant impact of 1) method choice and
2) OR side on FA values (see supplementary material, Table S1). Post-
hoc tests with Bonferroni correction revealed significant differences
between all methods except for the comparison of JHU-TBSS and CSD-
PROB in CIS/RRMS-NON, CIS/RRMS-ON and NMOSD-ON. ICC analysis
of absolute agreement of all FA values between methods showed poor
agreement between methods with ICC values ranging from 0.112 to
0.432 (see Table 2). Lower ICC values were found in patient groups
with no suspected visual system damage (HC) and in NMOSD-ON with
highest suspected OR damage whereas higher ICC agreement was found
in patient groups with suspected moderate damage (CIS/RRMS-ON and
CIS/RRMS-NON-group).
3.1.4. Inter-method agreement of FA values
Pearson correlation analysis revealed significant correlations when
analyzing all methods against each other with Pearson's r ranging from
0.2730 (JUEL-TBSS vs. CON-PROB) to 0.8714 (JUEL-TBSS vs. JHU-
TBSS; see Table 3, Fig. 2, Fig. S3).
Bland-Altman plots showed good agreement between all methods
with most FA values ranging within the 95% confidence interval from
average of differences. Best limits of agreement (LOA) were observed
between values of both TBSS-based approaches (LOA distance: 0.0934;
see Supplemental Fig. S4A; Table 4). Comparison of probabilistic trac-
tography based methods with TBSS based methods generally showed a
proportional error with overestimation of high FA values and under-
estimation of low FA values in probabilistic tractography (Fig. S4C and
E). Best agreement of relative and absolute FA values between all
methods were seen at medium FA values (0.45–0.5) suggesting good
agreement in methods in identifying minimal to medium damage.
3.2. Comparison of patient groups against healthy controls
3.2.1. Patient group differences from HC and effect size
Comparison of patient groups against healthy controls regarding T2
lesion volume, OCT RNFL, visual acuity and optic radiation FA values
are shown in Table 5. All patient groups showed higher T2 lesion vo-
lume and increased OR specific T2 lesion volume compared to HC.
RNFL was significantly decreased compared to HC in CIS/RRMS-ON
and NMOSD-ON, while visual impairment was only seen in NMOSD-ON
group. Linear model analysis of FA differences between each patient
group and healthy controls showed FA differences between NMOSD-ON
and HCs throughout all methodologies (JUEL-TBSS: p=0.0043; JHU-
TBSS: p= 0.0002; CON-PROB: p= 0.0024; CSD-PROB: p < 0.0001;
Fig. 3). p-Values and R2 as the effect size and proportion of variance
explained by the method are displayed in Table 6. Highest effect size in
the discrimination of HC and NMOSD was seen in CSD-PROB
(R2= 0.282). CSD-PROB revealed significant FA differences between
CIS/RRMS-ON patients and HCs, that were not observable when other
methods were applied.
Table 2
ICC analysis results of method comparisons by patient group.
All patients HC CIS/RRMS-NON CIS/RRMS-ON NMOSD-ON
All methodsa 0.155⁎ 0.024 0.208⁎ 0.252⁎ 0.074⁎
JUEL-TBSS vs. JHU-TBSS 0.389 0.215 0.391 0.350 0.527
JUEL-TBSS vs. CON-PROB 0.129⁎ −0.084 0.236⁎ 0.300⁎ −0.006
JUEL-TBSS vs. CSD-PROB 0.140 0.048 0.175 0.162 0.100
JHU-TBSS vs. CON-PROB 0.122 0.004 0.205 0.260 −0.003
JHU-TBSS vs. CSD-PROB 0.432⁎ 0.232⁎ 0.447⁎ 0.578⁎ 0.246⁎
CON-PROB vs. CSD-PROB 0.165 −0.014 0.085 0.155 0.061
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON= clinically isolated syndrome with prior optic
neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS= Juelich histological atlas optic radiation ROI based tract-
based spatial statistics; JHU-TBSS= Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB=Contrack-based
probabilistic tractography; CSD-PROB= constrained spherical deconvolution based probabilistic tractography.
⁎ p < 0.05.
a ICC analysis of all 4 methods (JUEL-TBSS, JHU-TBSS, CON-PROB and CSD-PROB).
Table 3
Pearson correlation analysis between all methods by patient groups.
All patients HC CIS/RRMS-NON CIS/RRMS-ON NMOSD-ON
Pearson's r p-Value Pearson's r p-Value Pearson's r p-Value Pearson's r p-Value Pearson's r p-Value
JUEL-TBSS vs. JHU-TBSS 0.8714 <0.0001⁎ 0.8076 <0.0001⁎ 0.8523 <0.0001⁎ 0.8683 <0.0001⁎ 0.9272 <0.0001⁎
JUEL-TBSS vs. CON-PROB 0.2730 0.0003⁎ −0.2188 0.1191 0.4967 0.0008⁎ 0.6002 0.0001⁎ −0.0151 0.9207
JUEL-TBSS vs. CSD-PROB 0.4186 <0.0001⁎ 0.2707 0.0523 0.4543 0.0025⁎ 0.6094 0.0002⁎ 0.2614 0.0864
JHU-TBSS vs. CON-PROB 0.3508 <0.0001⁎ 0.0164 0.9084 0.4494 0.0028⁎ 0.7063 <0.0001⁎ −0.0119 0.9372
JHU-TBSS vs. CSD-PROB 0.4883 <0.0001⁎ 0.2940 0.0344⁎ 0.5134 0.0005⁎ 0.6428 <0.0001⁎ 0.2836 0.0621
CON-PROB vs. CSD-PROB 0.2270 0.003⁎ −0.0629 0.6576 0.1509 0.3398 0.5423 0.0013⁎ 0.2695 0.0769
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON= clinically isolated syndrome with prior optic
neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior optic neuritis; JUEL-TBSS= Juelich histological atlas optic radiation ROI based tract-
based spatial statistics; JHU-TBSS= Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-PROB=Contrack-based
probabilistic tractography; CSD-PROB= constrained spherical deconvolution based probabilistic tractography.
⁎ p < 0.05.
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3.2.2. ROC-analysis
AUC values to discriminate HCs from NMOSD-ON were highest in
CSD-PROB (AUC=0.812), while slightly lower in CON-PROB
(AUC=0.742), JHU-TBSS (AUC=0.756) and JUEL-TBSS
(AUC=0.719; Fig. 4). ROC-analysis results of comparison between HC
vs. CIS/RRMS-ON and HC vs. CIS/RRMS-NON are shown in Table 7.
3.2.3. Tract profiling – subject group comparison
Tract profiles comparing patient groups are shown in Fig. 5. Sig-
nificant differences between NMOSD-were seen in both methods (CON-
PROB: nodes 26–47; CSD-PROB: nodes 20–25 and 48–50; Fig. 5).
3.2.4. OR-specific lesions and OR FA
We investigated possible correlations between OR FA values and
optic radiation specific lesion volume. JUEL-TBSS, JHU-TBSS and CSD-
PROB showed significant correlations between FA and OR T2 lesion
Fig. 2. Correlation of all FA values regarding each method.
Correlation of all OR FA values assessing A JUEL-TBSS vs. JHU-TBSS, B JUEL-TBSS vs. CON-PROB, C JUEL-TBSS vs. CSD-PROB, D JHU-TBSS vs. CON-PROB, E JHU-
TBSS vs. CSD-PROB, F CON-PROB vs. CSD-PROB.
JUEL-TBSS=Juelich-based atlas ROI TBSS approach; JHU-TBSS=Johns-Hopkins University posterior thalamic radiation ROI TBSS approach; CON-PROB=ConTrack-based
probabilistic tractography. CSD-PROB=constrained spherical deconvolution based probabilistic tractography. TBSS= tract-based spatial statistics; OR=optic radiation.
Table 4
Bias and limits of agreement of Bland-Altman analysis.
Estimation of bias 95% Limits of agreement (LOA)
Bias SD of bias From To
JUEL-TBSS vs. JHU-TBSS 0.0466 0.0206 0.0063 0.0871
JUEL-TBSS vs. CON-PROB 0.0218 0.0728 −0.1209 0.1646
JUEL-TBSS vs. CSD-PROB −0.0664 0.0452 −0.1550 0.0221
JHU-TBSS vs. CON-PROB 0.0922 0.0612 −0.0279 0.2123
JHU-TBSS vs. CSD-PROB −0.0198 0.0453 −0.1085 0.0689
CSD-PROB vs. CON-PROB 0.1121 0.0708 −0.0266 0.2508
SD= standard deviation; JUEL-TBSS= Juelich histological atlas optic radia-
tion ROI based tract-based spatial statistics; JHU-TBSS= Johns Hopkins
University atlas posterior thalamic ROI based tract-based spatial statistics;
CON-PROB=Contrack-based probabilistic tractography; CSD-
PROB= constrained spherical deconvolution based probabilistic tractography.
Table 5
Comparison of patient groups against healthy controls regarding T2 lesion volume, visual parameters and optic radiation FA values.
HC CIS/RRMS-NON CIS/RRMS-ON NMOSD-ON ANOVA p
Total T2 lesion volume [ml; mean ± sd] 0.38 ± 0.66 2.87⁎ ± 4.39 2.59⁎ ± 3.17 2.15⁎ ± 3.07 0.084
OR-specific T2 lesion volume [ml; mean ± sd] 0.04 ± 0.07 0.70⁎ ± 1.02 0.57⁎ ± 0.70 0.44⁎ ± 0.87 0.017⁎
RNFL [μm; mean ± sd] 96.90 ± 7.50 98.21 ± 12.16 87.92⁎ ± 14.76 67.12⁎ ± 19.72 < 0.001⁎
Visual acuity of worse eye [mean ± sd] 1.02 ± 0.31 1.00 ± 0.37 0.96 ± 0.29 0.74⁎ ± 0.47 0.003⁎
FA [JUEL-TBSS] 0.46 ± 0.02 0.46 ± 0.02 0.46 ± 0.02 0.44⁎ ± 0.03 0.012⁎
FA [JHU-TBSS] 0.52 ± 0.03 0.50 ± 0.04 0.51 ± 0.04 0.48⁎ ± 0.04 0.004⁎
FA [CON-PROB] 0.42 ± 0.06 0.43 ± 0.07 0.42 ± 0.06 0.38⁎ ± 0.06 0.010⁎
FA [CSD-PROB] 0.54 ± 0.03 0.52⁎ ± 0.04 0.53 ± 0.03 0.50⁎ ± 0.04 0.001⁎
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without prior optic neuritis; CIS/RRMS-ON= clinically isolated syndrome with prior optic
neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior optic neuritis; FA= fractional anisotropy; JUEL-TBSS= Juelich histological atlas optic
radiation ROI based tract-based spatial statistics; JHU-TBSS= Johns Hopkins University atlas posterior thalamic ROI based tract-based spatial statistics; CON-
PROB=Contrack-based probabilistic tractography; CSD-PROB= constrained spherical deconvolution based probabilistic tractography.
Exploratory ANOVA and subsequent t-test p-values.
⁎ p < 0.05 (significant from HC).
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volume in the CIS/RRMS-NON group (see Table 8).
3.2.5. RNFL and OR FA
Associations between RNFL and OR FA were exclusively shown in
the CIS/RRMS-NON group by all methods (see Table 8).
3.2.6. Visualy acuity and OR FA
Associations between visual acuity and OR FA were exclusively
shown in the CIS/RRMS-NON group by JUEL-TBSS and JHU-TBSS. (see
Table 8).
4. Discussion
Our study compared TBSS and probabilistic tractography based
approaches to quantify OR damage in patients with NMOSD-ON and
CIS with and without ON. While the distribution of absolute FA values
differed among methods, correlation analyses and Bland-Altman plots
revealed good agreement of FA values, especially in FA magnitudes of
suspected mild OR damage, reflected by OR-specific lesion load and
RNFL decrease (CIS/RRMS-ON and CIS/RRMS-NON). Both, TBSS and
probabilistic tractography methods detected microstructural damage in
NMOSD-ON patients compared to HCs.
4.1. Robustness of methods
CSD-PROB failed to generate OR tracts in one CIS/RRMS-ON pa-
tient, while successfully generating tracts in all other subjects. All other
methods successfully identified the ORs in all subjects. It has been re-
ported, that extensive white matter lesions in neurological disorders,
such as stroke or multiple sclerosis, may lead to erroneous termination
of the tracking algorithm or may cause a deviation of the bundles at the
level of the lesions (Ciccarelli et al., 2008). A previous study in stroke
patients showed that a CSD-based approach resulted in successful
Fig. 3. OR mean FA comparison of patient groups and HCs arranged by methods.
Mean FA distribution of individual TBSS skeletons within JUEL-TBSS (A) and JHU-TBSS (B). Both approaches show significant differences between HC and NMOSD
group. JHU also shows significant differences between NMOSD and all CIS groups and differences between HC and CIS and HC and CIS/RRMS-NON. Comparison of
weighted mean FA distribution within CON-PROB tracts (C) and CSD-PROB OR fibers (D) reveal similar significant differences between HC and NMOSD and NMOSD
with all CIS/RRMS-subgroups. CSD-PROB also reveals significant differences between HC and all CIS-subgroups.
FA= fractional anisotropy; HC=healthy controls; OR= optic radiation; TBSS= tract-based spatial statistics; JHU= Johns Hopkins University; ROI= region of
interest; CSD= constrained spherical deconvolution; NMOSD=neuromyelitis optica spectrum disorder.
* p < 0.05; ** p < 0.005; *** p < 0.0005; **** p < 0.0001.
Table 6
FA differences between patient groups and healthy controls.
CIS/RRMS-NON vs.
HC
CIS/RRMS-ON vs. HC NMOSD-ON vs. HC
p-Value R2 p-Value R2 p-Value R2
JUEL-TBSS 0.661 0.004 0.628 0.005 0.004⁎ 0.161
JHU-TBSS 0.134 0.049 0.362 0.020 < 0.001⁎ 0.262
CON-PROB 0.663 0.004 0.818 0.001 0.002⁎ 0.179
CSD-PROB 0.035⁎ 0.094 0.298 0.026 < 0.001⁎ 0.282
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without
prior optic neuritis; CIS/RRMS-ON=clinically isolated syndrome with prior
optic neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior
optic neuritis; JUEL-TBSS= Juelich histological atlas optic radiation ROI based
tract-based spatial statistics; JHU-TBSS= Johns Hopkins University atlas pos-
terior thalamic ROI based tract-based spatial statistics; CON-PROB=Contrack-
based probabilistic tractography; CSD-PROB= constrained spherical deconvo-
lution based probabilistic tractography.
⁎ p < 0.05.
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corticospinal tract reconstruction in 76 out of 78 tracts, while a com-
parative DTI-based fiber tractography resulted in the corticospinal tract
reconstruction in 67 out of 78 potential tracts (Auriat et al., 2015). For
both approaches unsuccessful fiber tract reconstruction occurred in the
ipsilesional hemisphere of participants, indicating lesions to be
responsible for insufficient tract generation and different tractography
to yield distinct susceptibilities towards lesion-associated tract gen-
eration failure (Auriat et al., 2015). In our study, unsatisfactory tract
generation in our CIS/RRMS-ON patient using CSD-PROB might be
caused by extensive white matter lesions that were observed in the
patient's optic radiations.
4.2. Inter-method comparison of FA distribution
In our study, CON-PROB showed highest coefficient of variation of
FA in HC, while JUEL-TBSS showed lowest coefficient of variation.
Supposing that a homogeneous and normally distributed cohort was
investigated, low coefficients of variation may suggest a correlate of
good method quality. High coefficients of variation in HCs in CON-
PROB, possibly caused by the mainly manual approach, might impair
the validity of the method. However, high coefficients may on the other
hand indicate higher method sensitivity. A recently published study
compared a) individual CON-PROB with b) healthy control-based CON-
PROB template OR reconstructions and c) Juelich histological atlas-
based OR ROI approach in 35 healthy controls and 70 MS patients
(Wang et al., 2018). Despite differences in the reconstructed OR vo-
lumes, both OR lesion volume and OR diffusivity measurements in MS
subjects were highly comparable in this study. The authors found dif-
fusivity differences between different OR segmentation techniques to be
consistently small across low and high values.
By contrast, the distribution of absolute OR FA values significantly
differed in our study between nearly all methods in all patient groups
and showed poor absolute agreement in the ICC analysis, except for
JHU-TBSS and CSD-PROB. We conclude that differences between
Fig. 4. ROC curves and AUCs for TBSS and CSD-based analysis methods.
ROC curves and AUCs are displayed comparing HC with NMOSD corrected for age by use of A JUEL-TBSS, B JHU-TBSS, C CON-PROB and D CSD-PROB.
ROC= receiver operating characteristics; AUC= area under the curve; HC=healthy controls; NMOSD=neuromyelitis optica spectrum disorder; TBSS= tract-
based spatial statistics; CSD= constrained spherical deconvolution; JHU=Johns Hopkins University.
Table 7
AUC values for the comparison of patient groups against healthy controls by
each method corrected for age.
Method Group 1 Group 2 AUC
JUEL-TBSS HC CIS/RRMS-NON 0.611
JUEL-TBSS HC CIS/RRMS-ON 0.625
JUEL-TBSS HC NMOSD-ON 0.719
JHU-TBSS HC CIS/RRMS-NON 0.743
JHU-TBSS HC CIS/RRMS-ON 0.704
JHU-TBSS HC NMOSD-ON 0.756
CON-PROB HC CIS/RRMS-NON 0.704
CON-PROB HC CIS/RRMS-ON 0.523
CON-PROB HC NMOSD-ON 0.742
CSD-PROB HC CIS/RRMS-NON 0.796
CSD-PROB HC CIS/RRMS-ON 0.626
CSD-PROB HC NMOSD-ON 0.812
HC=healthy control; CIS/RRMS-NON=clinically isolated syndrome without
prior optic neuritis; CIS/RRMS-ON=clinically isolated syndrome with prior
optic neuritis; NMOSD-ON=neuromyelitis optica spectrum disorder with prior
optic neuritis; JUEL-TBSS= Juelich histological atlas optic radiation ROI based
tract-based spatial statistics; JHU-TBSS= Johns Hopkins University atlas pos-
terior thalamic ROI based tract-based spatial statistics; CON-PROB=Contrack-
based probabilistic tractography; CSD-PROB= constrained spherical deconvo-
lution based probabilistic tractography.
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absolute OR FA values may impede comparisons of previous and future
DTI study results investigating microstructural OR damage. The appli-
cation of the exact same method is therefore necessary to allow for any
statements on possible differences between OR FA values within a
specific cohort of patients. These findings may be of particular sig-
nificance in any case of OR DTI comparison, regardless of within-study
analyses or comparisons of OR DTI results between studies, for example
in meta-analyses. Comparisons of absolute OR DTI values that did not
use the same post-processing approach are not valid and must therefore
be avoided.
4.3. Inter-method comparison of FA correlations and agreement
OR FA values of all methods showed significant correlations sug-
gesting underlying associations of FA values and actual OR specific
microstructural damage regardless of method choice. Subgroup ana-
lyses of Pearson correlation coefficient analyses revealed best correla-
tions of OR FA values in CIS/RRMS-ON and CIS/RRMS-NON. These
findings are in line with a recent study reporting on good agreement
between CON-PROB, template-based OR reconstruction and a Juelich
OR ROI-based approach in HC and MS measured by Pearson correlation
coefficents and Bland-Altman analysis (Wang et al., 2018).
By contrast, only limited correlations of OR FA values were seen in
our study in the non-damage group (HC) and patients with suspected
extensive OR damage (NMOSD-ON).
In a recent study, CSD-PROB was investigated in ten HCs and five
MS patients to compare tractography results with histological masks. It
showed a good sensitivity ranging from 65% to 81% and a specificity up
to 100% (Martínez-Heras et al., 2015). Another recent study compared
CSD-PROB with Juelich histological atlas in 20 patients with various
neurological conditions, showing a good match of the probabilistic
tractography approach with a mean AUC of 0.87 (Lim et al., 2015).
These findings are in line with our study showing relatively little bias
between JUEL-TBSS masking approach and CSD-PROB in the conducted
Bland-Altman analysis. Bland-Altman analysis revealed best agreement
between all methods at medium FA values (0.45–0.5) suggesting good
agreement of methods in identifying damage of medium magnitude
(CIS/RRMS-ON and CIS/RRMS-NON). These findings might – at least to
a certain extent – suggest the convertibility of results by different DTI
post-processing methods when applied to patient groups with OR da-
mage of mild to moderate magnitude. Concrete research approaches to
Fig. 5. Tract profiles of the optic radiation in different patient groups.
OR partitioning into 50 equally divided nodes in NMOSD (red), CIS/RRMS-ON
(orange) and CIS/RRMS-NON (yellow) patients and Healthy controls (green)
using (A) Contrack-based probabilistic tractography (B) CSD-based tracto-
graphy.
OR=optic radiation; CIS= clinically isolated syndrome; ON=optic neuritis;
CSD= constrained spherical deconvolution; NMOSD=neuromyelitis optica
spectrum disorder; FA= fractional anisotropy.
Table 8
Correlations of optic radiation specific lesion volume, RNFL and visual acuity with optic radiation FA values by method.
JUEL-TBSS JHU-TBSS CON-PROB CSD-PROB
Estimate Std error p-Value Estimate Std error p-Value Estimate Std error p-Value Estimate Std error p-Value
OR T2 Lesion volume
HC −0.073 0.060 0.23 −0.124 0.089 0.17 0.152 0.142 0.29 0.026 0.108 0.24
CIS/RRMS-NON −0.022 0.005 <0.01⁎ −0.044 0.008 <0.01⁎ −0.022 0.017 0.21 −0.031 0.012 0.01⁎
CIS/RRMS-ON −0.011 0.009 0.26 −0.022 0.015 0.15 −0.014 0.023 0.54 −0.027 0.014 0.06
NMOSD-ON −0.010 0.007 0.18 −0.013 0.008 0.15 −0.016 0.011 0.15 −0.003 0.009 0.76
RNFL
HC 0.001 0.000 0.57 0.001 0.000 0.98 0.001 0.000 0.37 0.001 0.000 0.21
CIS/RRMS-NON 0.001 0.000 <0.01⁎ 0.002 0.000 <0.01⁎ 0.002 0.000 0.01⁎ 0.001 0.001 0.01⁎
CIS/RRMS-ON 0.001 0.000 0.06 0.001 0.000 0.24 0.001 0.000 0.10 0.001 0.000 0.07
NMOSD-ON 0.000 0.000 0.52 0.001 0.000 0.74 0.001 0.000 0.32 0.001 0.000 0.44
Visual acuity
HC 0.022 0.008 0.01⁎ 0.019 0.019 0.12 −0.055 0.019 <0.01⁎ 0.024 0.011 0.03⁎
CIS/RRMS-NON 0.026 0.008 <0.01⁎ 0.041 0.015 0.01⁎ 0.021 0.027 0.44 0.010 0.017 0.55
CIS/RRMS-ON 0.012 0.011 0.30 0.014 0.017 0.45 0.033 0.024 0.17 0.011 0.019 0.56
NMOSD-ON 0.016 0.001 0.10 0.012 0.011 0.28 0.006 0.014 0.68 0.003 0.012 0.77
JUEL-TBSS= Juelich histological atlas optic radiation ROI based tract-based spatial statistics; JHU-TBSS= Johns Hopkins University atlas posterior thalamic ROI
based tract-based spatial statistics; CON-PROB=Contrack-based probabilistic tractography; CSD-PROB= constrained spherical deconvolution based probabilistic
tractography. RNFL= retinal nerve fiber layer thickness. Significant p-values are displayed in bold.
⁎ p < 0.05.
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patient groups with suspected mild OR damage, for example CIS pa-
tients, could be sufficiently tackled by all investigated methods, while
investigations regarding HCs or severely affected patient groups
(NMOSD-ON) might lead to different results, highly dependent of the
chosen method.
The presence of systematic bias and proportional errors in the
comparison of DTI TBSS-based and tractography based methods may
lead to false positive or false negative results when different patient
groups are compared by different methods. While one method might
produce significant differences in group comparison due to under-
estimation of low FA values, another method may yield non-significant
results due to relative overestimation of low FA values. These findings
might be a causative factor of today's equivocal findings (Assaf and
Pasternak, 2008) of previous DTI visual pathway analyses that impede
the evaluation of DTI as a potential biomarker (Inglese and Bester,
2010).
4.4. NMOSD vs. HC group comparison
Group comparison showed FA differences between NMOSD-ON and
HCs throughout all TBSS and probabilistic tractography based methods.
Best effect size and AUC values to distinguish both groups were ob-
served for CSD-PROB. JHU-TBSS, JUEL-TBSS and CON-PROB showed
slightly lower AUC values and effect size. Our study results are in line
with previous investigations using DTI reporting on microstructural
degradation with significant FA reduction within the OR (Oertel et al.,
2017; Pache et al., 2016a, 2016b; Rueda Lopes et al., 2012; Yu et al.,
2006). A previous study in NMOSD patients, using TBSS, found FA
values to be exclusively reduced in regions associated to the visual
system by making use of a TBSS ROI and a multivariate comparison
approach. These results provide evidence of anterograde trans-synaptic
degeneration due to ON (Pache et al., 2016a, 2016b). By contrast, one
TBSS-based study demonstrated reduced FA involving not only the OR
but also diffuse subcortical white matter structures in frontal, parietal,
temporal, occipital and limbic regions (von Glehn et al., 2014). Another
study used CSD-PROB OR tractography and revealed FA reductions
within the OR of 25 AQP4-antibody seropositive NMOSD patients
(Oertel et al., 2017). Notably, OR FA was not only reduced in NMOSD
patients with previous ON but FA reductions were also detectable in 6
NMOSD patients with longitudinally extensive transverse myelitis
(LETM) without evidence of prior ON. These results were corroborated
by another study that used FSL-based probabilistic tractography (FSL's
probtrackx) to delineate the OR and found FA reduction within the OR
of 24 NMOSD patients with prior ON (58.3% AQP4-antibody ser-
opositive) as well as in 12 NMOSD patients without prior ON (66.6%
AQP4-antibody positive) (Tian et al., 2017). These findings suggest
microstructural changes in the afferent visual system independent of
ON attack-related mechanisms.
Although clinical history of our NMOSD patients with prior uni-
lateral or bilateral ON, long disease duration and pronounced visual
impairment and OCT RNFL thinning suggests the presence of attack-
related optic radiation FA decrease in our NMOSD cohort, we did not
find any direct associations between OCT RNFL or visual acuity and
optic radation FA, irrespective of the method. However, our data mirror
the clinical experience as well as findings from conventional imaging
studies showing that neurological disability and tissue damage in the
visual pathway are on average more pronounced in NMOSD as com-
pared to MS/CIS, as it can be seen in the relatively frequent bilateral
manifestation of optic neuritis in our NMOSD-cohort compared to CIS/
RRMS-ON (Bennett et al., 2015; Kim et al., 2015; Schmidt et al., 2017).
4.5. CIS/RRMS-ON and CIS/RRMS-NON vs. HC
No difference of OR FA between CIS/RRMS-ON and HC was seen in
any of the methods used. CSD-PROB showed differences between HC
and CIS/RRMS-NON. In CIS and early stages of MS, OR microstructural
damage is most likely caused by 1) trans-synaptic neurodegeneration
after ON (Gabilondo et al., 2014) and 2) impact of T2 inflammatory
lesions within the OR (Graham and Klistorner, 2017; Sinnecker et al.,
2015a, 2015b).
Damage in the OR of ON patients due to inflammatory T2 lesions
has been investigated previously. Raz et al. reported on reduced OR FA
by making use of CON-PROB in patients with clinically isolated ON
compared to healthy controls. In this study, reduced OR FA was asso-
ciated with OR specific T2 lesion volume suggesting FA differences to
be explained by intrabundle lesions (Raz et al., 2015). In our CIS/
RRMS-NON cohort, OR FA in JUEL-TBSS, JHU-TBSS and CSD-PROB
was associated with OR specific T2 lesion volume, indicating TBSS
approaches to be more sensitive to lesional damage than probabilistic
tractography approaches. These findings indicate lesional damage to be
at least partly responsible for damage within the ORs of CIS/RRMS
patients without prior ON. However, recent findings indicated the
presence of a measurable, time-dependent trans-synaptic neurodegen-
eration effect on the OR after ON, independent of T2 lesion load.
Longitudinal investigations using an atlas-based OR template ROI in 38
acute ON patients over 12months showed FA reduction at baseline and
subsequent additional FA decrease at an average rate of −2.6% per
year (Kolbe et al., 2016). Another study investigated twenty-eight acute
ON patients by use of the FSL based probabilistic tractography algo-
rithm and found no difference between patients' and controls' mean OR
FA at baseline but a constant decrease over time after 3, 6 and
12months (Tur et al., 2016). No associations between RNFL and OR FA
were found in CIS/RRMS-ON patients. Given the relatively short time
after ON in our CIS/RRMS-ON cohort with a mean disease duration of
4.63 ± 5.15months after ON, we presume that the early timepoint of
MRI acquisition after ON makes the determination of any trans-synaptic
effect on the optic radiations unlikely.
4.6. Tract profiling using probabilistic tractography methods
Tract-profiling group differences between HC and NMOSD were
seen in higher proportion of nodes in CON-PROB compared to CSD-
PROB, indicating CON-PROB tract-profiling to yield higher sensitivity
for the detection of microstructural OR damage in NMOSD compared to
CSD-PROB tract profiling. Using CON-PROB, tract-profiling enabled the
distinction between OR fibers affected by T2 lesions and non-lesional
OR fibers. Radial diffusivity, mean diffusivity and FA changes were
detected along the entire OR, while axial diffusivity changes were
confined to the posterior half of the OR. This discrepancy implied dis-
tinct pathophysiologic processes to be detectable by DTI tract profiling
(Klistorner et al., 2015).
In our study, tract profiling showed middle and posterior parts of
the OR to be more affected than anterior OR sections in NMOSD
compared to HC. These findings may suggest distinct regions of the OR
to exhibit more pronounced damage by trans-synaptic neurodegenera-
tion or distinct OR T2 lesional damage affecting only specific regions of
the OR due to Wallerian degeneration (Klistorner et al., 2015). How-
ever, in our analysis overall NMOSD OR FA was not associated with
optic radiation T2 lesion volume. Distinct regions of the OR are sup-
posed to be less affected by contamination from craniocaudally oriented
crossing fibers to the optic radiation. Neighbouring and crossing white
matter pathways may additionally lead to a reduced FA in OR fiber
regions (Kamali et al., 2014). Exclusive microstructural OR damage is
more likely to be observable by DTI in regions that are not affected by
crossing or kissing fibers, which are represented by distinct middle and
posterior parts of the OR. Both, the affection of the OR by crossing and
kissing fibers, as well as distinct damage patterns caused by the loca-
lization of OR-specific T2 lesions or trans-synaptic neurodegeneration
damage patterns may therefore be the cause of different levels in FA
decrease along OR regions.
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4.7. Technical aspects
TBSS can be implemented fully-automated requiring no manual
intervention. In TBSS, the average FA may be affected by surrounding
structures due to partial voluming (Smith et al., 2006). Probabilistic
tractography is more time-consuming due to manual and calculation
processes inherent to the specific algorithm (Wang et al., 2018). Trac-
tography algorithms are known to be - at least to a certain extent -
susceptible to image artifacts with possible insufficient tract generation
(Auriat et al., 2015). However, the CSD-PROB approach used in our
study represents a feasible and fully-automated probabilistic tracto-
graphy method, requiring no manual intervention compared to pre-
viously used CON-PROB (Wang et al., 2018).
4.8. Limitations
Given the multitude of methods that exist for tractography and the
comparison of DWI measures, our study naturally fails to comprehen-
sively include all alternative methods for comparison. Our study is
limited by the small sample size of the respective subpopulations mi-
tigating validity of our cross-method comparison.
5. Conclusion
To our knowledge, this is the first study to compare multiple
probabilistic tractography and TBSS-based approaches to quantify mi-
crostructural OR damage in patients with neuroinflammatory visual
pathway damage. We proved TBSS-based and probabilistic tracto-
graphy based DWI processing techniques to be feasible in detecting
microstructural damage within the OR. Absolute FA values differed
between the methods, preventing comparisons of OR FA analyses of
previous and future studies with different post-processing approaches.
Correlation and agreement of all methods' FA values were best in pa-
tients with suggested mild to moderate OR FA damage (CIS/RRMS
patients), indicating methods to be exchangeable – at least to a certain
extent – in the analysis of CIS/RRMS patients but not if healthy controls
or patients with suspected severe damage (NMOSD-ON) are in-
vestigated. Due to systematic bias and proportional errors of FA be-
tween methods, the comparison of subject groups by use of different
methods leads to different (either false-positive or false-negative) re-
sults. Although the pattern of differences between the patient cohorts
was similar in our study, CSD-PROB showed significant FA differences
between HC and CIS/RRMS-NON patients. Although these CSD-PROB
derived differences between the groups could result from the above-
mentioned systematic bias, we suggest CSD-PROB to be more sensitive
to early neuroinflammatory damage, partially associated with lesions.
All methods were successful in differentiating NMOSD-ON patients
from HCs. Given that CSD-PROB showed highest AUC and effect size
followed by JHU-TBSS, JUEL-TBSS and CON-PROB, CSD-PROB ap-
proach might be the method of choice to further investigate differential
diagnostic aspects between HC and NMOSD. Tract-profiling differences
between HC and NMOSD were more pronounced in CON-PROB, which
might be the method of choice for tract profiling assessments. In our
study, TBSS-based approaches showed better correlations with OR
specific lesions, which could favor them as the method of choice for
future studies to investigate the relationship between T2 lesions and
DTI. Given the lack of a “gold-standard” for non-invasive DW-MRI OR
delineation (Kuchling et al., 2017; Lim et al., 2015; Thomas et al.,
2014), future studies are required to fully validate the capacity and
limitations of different post-processing methods with regards not only
to differential diagnosis and T2 lesional impact on DTI, but also con-
cerning longitudinal FA assessment and OR DTI relationships with vi-
sual function.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.nicl.2018.05.004.
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